148 related articles for article (PubMed ID: 18083920)
1. Nephroblastoma overexpressed (Nov) is a novel bone morphogenetic protein antagonist.
Canalis E
Ann N Y Acad Sci; 2007 Nov; 1116():50-8. PubMed ID: 18083920
[TBL] [Abstract][Full Text] [Related]
2. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
Rydziel S; Stadmeyer L; Zanotti S; Durant D; Smerdel-Ramoya A; Canalis E
J Biol Chem; 2007 Jul; 282(27):19762-72. PubMed ID: 17500060
[TBL] [Abstract][Full Text] [Related]
3. CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways.
Minamizato T; Sakamoto K; Liu T; Kokubo H; Katsube K; Perbal B; Nakamura S; Yamaguchi A
Biochem Biophys Res Commun; 2007 Mar; 354(2):567-73. PubMed ID: 17250806
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of CCN genes in murine osteoblasts.
Parisi MS; Gazzerro E; Rydziel S; Canalis E
Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
[TBL] [Abstract][Full Text] [Related]
5. Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
Smerdel-Ramoya A; Zanotti S; Stadmeyer L; Durant D; Canalis E
Endocrinology; 2008 Sep; 149(9):4374-81. PubMed ID: 18535099
[TBL] [Abstract][Full Text] [Related]
6. Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis.
Canalis E; Smerdel-Ramoya A; Durant D; Economides AN; Beamer WG; Zanotti S
Endocrinology; 2010 Jan; 151(1):221-33. PubMed ID: 19934377
[TBL] [Abstract][Full Text] [Related]
7. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
8. The role of connective tissue growth factor in skeletal growth and development.
Kanaan RA; Aldwaik M; Al-Hanbali OA
Med Sci Monit; 2006 Dec; 12(12):RA277-281. PubMed ID: 17136017
[TBL] [Abstract][Full Text] [Related]
9. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.
Abreu JG; Ketpura NI; Reversade B; De Robertis EM
Nat Cell Biol; 2002 Aug; 4(8):599-604. PubMed ID: 12134160
[TBL] [Abstract][Full Text] [Related]
10. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
11. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation.
Grotendorst GR; Duncan MR
FASEB J; 2005 May; 19(7):729-38. PubMed ID: 15857887
[TBL] [Abstract][Full Text] [Related]
12. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
[TBL] [Abstract][Full Text] [Related]
14. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
Perbal B
Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor enhances osteoblastogenesis in vitro.
Smerdel-Ramoya A; Zanotti S; Deregowski V; Canalis E
J Biol Chem; 2008 Aug; 283(33):22690-9. PubMed ID: 18583340
[TBL] [Abstract][Full Text] [Related]
17. Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates.
Desnoyers L
Curr Pharm Des; 2004; 10(31):3913-28. PubMed ID: 15579080
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
Denton CP; Abraham DJ
Curr Opin Rheumatol; 2001 Nov; 13(6):505-11. PubMed ID: 11698729
[TBL] [Abstract][Full Text] [Related]
19. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
Brigstock DR
Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
[TBL] [Abstract][Full Text] [Related]
20. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]